Hints and tips:
Showing results for TEVA PHARMACEUTICALS, USA, INC.
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...It exited its position in generic drugs maker Teva and sold more than 70 per cent of its remaining shares in AbbVie and Bristol-Myers Squibb....
...That might justify a steeper EV-to-forward ebitda multiple than the seven times commanded by quoted generics companies Teva and Viatris. The unit might fetch at least $15bn, according to Bernstein....
...Its case against Endo, Teva, and Allergan is currently being tried in state court. The settlement payments to New York will begin this summer and continue over the next 17 years....
...James added that the pharmaceutical company’s heavy marketing of opioids was partially motivated by quotas for sales staff....
...The company already held stakes in the drugmakers Biogen, Johnson & Johnson and Teva Pharmaceuticals and DaVita, a kidney dialysis company. Mr Buffett did not respond to a request for comment....
...“I feel very strongly that we should get as many shots in arms as possible, right away,” Mr Gottlieb told USA Today last week. “The reality is that one dose is partially protective....
...The Pfizer vaccine, which needs to be kept at under minus 70 degrees Celsius during transit, is transported from Ben Gurion airport to logistics centres run by a subsidiary of Teva Pharmaceuticals, a global...
...To boost supplies of antimalarials, generics manufacturers Teva and Novartis’ Sandoz have pledged to donate millions of doses to US hospitals....
...Teva, Mylan and others in the lawsuits have denied wrongdoing....
...Teva Pharmaceuticals, the only remaining manufacturer, fell 1.6 per cent to $7.38, after losing 3.5 per cent during the trading day....
...Endo International, a pharmaceutical company, fell 9 per cent to $2.65; Teva, the Israeli drugmaker, lost 4.6 per cent to $7.08; and McKesson, another distributor, fell 3 per cent to $142.55 in late-morning...
...There are civil suits against much larger companies including Johnson & Johnson and Teva, as well as distributors and pharmacies....
...The state argued that J&J’s previous ownership of Noramco and Tasmanian Alkaloids, units which produced the active pharmaceutical ingredient in opioids and supplied to Purdue and Teva, made it a “drug kingpin...
...Earlier this year Purdue Pharma settled the Oklahoma case for $270m without admitting liability, and Israeli drugmaker Teva Pharmaceuticals settled for $85m....
...Pfizer has reached a deal to spin off its Upjohn unit and combine it with generics drugmaker Mylan to create an off-patent pharmaceutical group with an enterprise valuation of about $50bn....
...In particular, WBA pointed to a 2.3 per cent year-on-year rise in sales at its main Retail Pharmacy USA division, with a rise in pharmacy sales offsetting declining retail sales....
...Plus, the FT’s pharmaceutical and biotech reporter, Hannah Kuchler, explains why a lawsuit backed by 44 US states alleges that some generic drugmakers, including Teva and Pfizer, have been fixing prices...
...In September last year, Novartis said it would sell parts of the Sandoz US business to Aurobindo Pharma USA to focus on “higher growth areas”....
...Many are civil cases brought by state attorneys-general, including a case against Johnson & Johnson and Teva Pharmaceuticals set to go to trial in Oklahoma at the end of May....
...The 2016 pricing controversy made it clear that there was a problem, yet an attempt by Teva, the Israeli pharmaceutical group, to introduce a generic auto-injector has been stuck in the FDA’s approvals process...
...On Thursday, Novartis said it would sell portions of the Sandoz US portfolio to Aurobindo Pharma USA in order to focus on “higher growth areas”....
...Israeli drugmaker Teva Pharmaceutical’s US shares shot up in after-hours trade on Wednesday after Berkshire Hathaway said it had taken a new stake in the company, signalling confidence by famed investor...
...“Anyone with the appetite and dollars to buy can, whether it’s a Patrick Soon-Shiong [the pharmaceuticals billionaire who owns the LA Times] or an Alden.”...
...Pfizer is the sole supplier of vincristine, while Teva makes a branded version of the medicine known as Vincasar....
International Edition